Dr. John K Brendel Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2021 Cenex Dr Unit J, Rice Lake, WI 54868 Phone: 715-234-7246 Fax: 715-234-7242 |
Dr. Mark A Weber, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-234-1515 |
Dr. Douglas J Raether, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100 |
Jeffrey J Anderegg, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100 |
Dr. Philip S. Henkel, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2256 18th St, Rice Lake, WI 54868 Phone: 715-234-7011 |
News Archive
Sinks situated next to patient toilets in hospital rooms may be reservoirs for Klebsiella pneumoniae carbapenemase, increasing the risk of dangerous germ transmission, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
Scientists at the Gladstone Institutes have discovered an unusual regulator of body weight and the metabolic syndrome: a molecular mechanism more commonly associated with brain cells. Lowering levels of P75 neurotrophin receptor (NTR)-a receptor involved in neuron growth and survival-protected mice fed a high-fat diet from developing obesity, diabetes, and fatty liver disease.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
Marijuana use episodes among couples who frequently use the drug increase the likelihood of experiencing intimacy events, according to the results of a University at Buffalo-led study.
› Verified 4 days ago